Key result
Higher TyG index variability linked to ~66% greater in-hospital mortality, outperforming baseline measurements.
Why the study?
The study aimed to evaluate the association between triglyceride-glucose index variability and in-hospital mortality in critically ill patients, and whether variability adds prognostic value over baseline levels.
Does high triglyceride-glucose index variability increase in-hospital mortality in critically ill patients?
Observational (n=2,208)
Yes
Does high triglyceride-glucose index variability increase in-hospital mortality in critically ill patients?
Dynamic fluctuations in the triglyceride-glucose (TyG) index provide significant prognostic value for in-hospital mortality in critically ill patients beyond a single baseline measurement.
May enhance risk stratification in critically ill patients; extends prognostic value of baseline TyG index and requires prospective validation.
This study aims to evaluate the relationship between triglyceride-glucose (TyG) index variability and in-hospital mortality across two intensive care unit (ICU) databases (MIMIC-IV and SWH) and to determine if TyG variability provides more prognostic value than baseline TyG. This retrospective observational study utilized data from the MIMIC-IV (2008-2019) and SWH (2016-2023) ICU cohorts. TyG metrics, including baseline (TyG-BL), median (TyG-Median), mean (TyG-Average), standard deviation (TyG-STD), range (TyG-Range), and coefficient of variation (TyG-CV), were calculated. The association between TyG metrics and all-cause in-hospital mortality was evaluated using multivariable logistic regression. Nonlinear relationships were explored using restricted cubic splines (RCS). Cox proportional hazards models and subgroup analyses were conducted as sensitivity analyses, and post-discharge mortality at 7 days, 1 year, and 2 years was additionally assessed. A total of 2,208 ICU patients were included (MIMIC: n = 1707; SWH: n = 501). In MIMIC, TyG variability metrics (TyG-STD, TyG-Range) were independently associated with mortality, with TyG-STD showing an odds ratio (OR) of 1.66 (95% confidence interval [CI] 1.06-2.61, P = 0.027) and TyG-Range an OR of 1.24 (95% CI 1.05-1.46, P = 0.011). TyG variability metrics in SWH showed similar trends, but associations attenuated after full adjustment. Kaplan-Meier analysis demonstrated clear survival curve separation for TyG variability metrics in MIMIC, while the SWH cohort showed weaker separation. RCS analysis revealed a nonlinear relationship between TyG metrics and mortality risk in MIMIC, with a steeper increase in risk at higher TyG values. In Cox analyses, baseline TyG was associated with the timing of in-hospital death in MIMIC, whereas TyG variability metrics were not. No significant associations were observed between TyG metrics and post-discharge mortality. TyG variability, rather than a single baseline TyG measurement, is associated with in-hospital mortality in critically ill patients, particularly in the MIMIC cohort. These findings suggest that dynamic metabolic instability may provide clinically relevant prognostic information beyond static measurements. Further prospective and multicenter studies are warranted to validate the role of TyG variability in ICU risk stratification.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2026) conducted an observational in Critically ill patients (n=2,208). Triglyceride-glucose (TyG) index variability vs. Baseline TyG index was evaluated on In-hospital all-cause mortality (OR 1.66, 95% CI 1.06-2.61, p=0.027). Higher triglyceride-glucose index variability (TyG-STD) was independently associated with increased in-hospital mortality (OR 1.66) in critically ill patients, outperforming baseline measurements.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: